541 related articles for article (PubMed ID: 15794776)
1. Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate-specific antigen testing: 15-year outcome.
Ward JF; Slezak JM; Blute ML; Bergstralh EJ; Zincke H
BJU Int; 2005 Apr; 95(6):751-6. PubMed ID: 15794776
[TBL] [Abstract][Full Text] [Related]
2. Comparative effectiveness of radical prostatectomy with adjuvant radiotherapy versus radiotherapy plus androgen deprivation therapy for men with advanced prostate cancer.
Jang TL; Patel N; Faiena I; Radadia KD; Moore DF; Elsamra SE; Singer EA; Stein MN; Eastham JA; Scardino PT; Lin Y; Kim IY; Lu-Yao GL
Cancer; 2018 Oct; 124(20):4010-4022. PubMed ID: 30252932
[TBL] [Abstract][Full Text] [Related]
3. Secondary therapy, metastatic progression, and cancer-specific mortality in men with clinically high-risk prostate cancer treated with radical prostatectomy.
Yossepowitch O; Eggener SE; Serio AM; Carver BS; Bianco FJ; Scardino PT; Eastham JA
Eur Urol; 2008 May; 53(5):950-9. PubMed ID: 17950521
[TBL] [Abstract][Full Text] [Related]
4. Surgery with or Without Darolutamide in High-risk and/or Locally Advanced Prostate Cancer: The SUGAR (CCAFU-PR2) Phase 2 Trial Rationale and Protocol.
Calleris G; Filleron T; Kesch C; Roubaud G; Pradère B; Cabarrou B; Malavaud B; Roupret M; Mourey L; Ploussard G
Eur Urol Oncol; 2024 Jun; 7(3):494-500. PubMed ID: 37806843
[TBL] [Abstract][Full Text] [Related]
5. Use of prostate-specific antigen testing as a disease surveillance tool following radical prostatectomy.
Trantham LC; Nielsen ME; Mobley LR; Wheeler SB; Carpenter WR; Biddle AK
Cancer; 2013 Oct; 119(19):3523-30. PubMed ID: 23893821
[TBL] [Abstract][Full Text] [Related]
6. Age-adjusted Charlson Comorbidity Index as a prognostic factor for radical prostatectomy outcomes of very high-risk prostate cancer patients.
Park JW; Koh DH; Jang WS; Lee JY; Cho KS; Ham WS; Rha KH; Jung WH; Hong SJ; Choi YD
PLoS One; 2018; 13(6):e0199365. PubMed ID: 29924851
[TBL] [Abstract][Full Text] [Related]
7. Role of cytoreductive radical prostatectomy in men with oligometastatic prostate cancer on molecular imaging.
Robesti D; Gallina A; Montorsi F; Briganti A; Fossati N
Curr Opin Urol; 2024 Jul; 34(4):294-299. PubMed ID: 38587018
[TBL] [Abstract][Full Text] [Related]
8. Difference in Incontinence Pad Use between Patients after Radical Prostatectomy and Cancer-Free Population with Subgroup Analysis for Open vs. Minimally Invasive Radical Prostatectomy: A Descriptive Analysis of Insurance Claims-Based Data.
Mun DH; Yang L; Shariat SF; Reitter-Pfoertner S; Gredinger G; Waldhoer T
Int J Environ Res Public Health; 2021 Jun; 18(13):. PubMed ID: 34199008
[TBL] [Abstract][Full Text] [Related]
9. Predictors of time to biochemical recurrence in a radical prostatectomy cohort within the PSA-era.
Shahabi A; Satkunasivam R; Gill IS; Lieskovsky G; Daneshmand S; Pinski JK; Stern MC
Can Urol Assoc J; 2016; 10(1-2):E17-22. PubMed ID: 26858782
[TBL] [Abstract][Full Text] [Related]
10. The effect of a fermented soy beverage among patients with localized prostate cancer prior to radical prostatectomy.
Lokeshwar SD; Ali A; Weiss TR; Reynolds J; Shuch BM; Ferencz T; Kyriakides TC; Mehal WZ; Brito J; Renzulli J; Leapman MS
BMC Urol; 2024 May; 24(1):102. PubMed ID: 38702664
[TBL] [Abstract][Full Text] [Related]
11. Is radical prostatectomy a useful therapeutic option for high-risk prostate cancer in older men?
Graefen M; Schlomm T
Oncologist; 2012; 17 Suppl 1(Suppl 1):4-8. PubMed ID: 23015679
[TBL] [Abstract][Full Text] [Related]
12. SABRE 1 (Surgery Against Brachytherapy - a Randomised Evaluation): feasibility randomised controlled trial (RCT) of brachytherapy vs radical prostatectomy in low-intermediate risk clinically localised prostate cancer.
Eccles BK; Cross W; Rosario DJ; Doble A; Parker C; Logue J; Little L; Stanton L; Bottomley D
BJU Int; 2013 Aug; 112(3):330-7. PubMed ID: 23826842
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and determinants of decision regret in long-term prostate cancer survivors following radical prostatectomy.
Lunger L; Meissner VH; Kopp BCG; Dinkel A; Schiele S; Ankerst DP; Gschwend JE; Herkommer K
BMC Urol; 2023 Aug; 23(1):139. PubMed ID: 37612591
[TBL] [Abstract][Full Text] [Related]
14. Feasibility and safety of radical prostatectomy for oligo-metastatic prostate cancer: the Testing Radical prostatectomy in men with prostate cancer and oligo-Metastases to the bone (TRoMbone) trial.
Sooriakumaran P; Wilson C; Rombach I; Hassanali N; Aning J; D Lamb A; Cathcart P; Eden C; Ahmad I; Rajan P; Sridhar A; Bryant RJ; Elhage O; Cook J; Leung H; Soomro N; Kelly J; Nathan S; Donovan JL; Hamdy FC
BJU Int; 2022 Jul; 130(1):43-53. PubMed ID: 34878715
[TBL] [Abstract][Full Text] [Related]
15. Patient Benefits of Radical Prostatectomy in Certified Prostate Cancer Centers: Comparative Results from the Multicenter IMPROVE Study.
Sikic D; Fiebig C; Wullich B; Wolff I; Hoschke B; Manseck A; Gillitzer R; Burger M; Steinestel J; Harke N; Löbig N; Distler FA; May M; Peter J; Gilfrich C
Urol Int; 2023; 107(10-12):949-958. PubMed ID: 37931610
[TBL] [Abstract][Full Text] [Related]
16. [Study on the efficacy and complications of patients undergoing radical surgery and radical radiotherapy for localized prostate cancer].
Shi XQ; Wang SH; Liu Z; Lu LW; Xu S; Fu D; Cheng W
Zhonghua Nan Ke Xue; 2023 Oct; 29(10):910-915. PubMed ID: 38639661
[TBL] [Abstract][Full Text] [Related]
17. Prognosis after radical prostatectomy in men older than 75 years: long-term results from a single tertiary center.
Lee J; Song J; Jung G; Song SH; Hong SK
Prostate Int; 2024 Mar; 12(1):15-19. PubMed ID: 38523903
[TBL] [Abstract][Full Text] [Related]
18. Testosterone therapy in men with prostate cancer: literature review, clinical experience, and recommendations.
Morgentaler A; Conners WP
Asian J Androl; 2015; 17(2):206-11. PubMed ID: 25652633
[TBL] [Abstract][Full Text] [Related]
19. Improvement of Mental Health and Quality of Life of Patients after Radical Prostatectomy through Continuous Nursing Based on Internet Technology: A Retrospective Study.
Fang X
Arch Esp Urol; 2024 May; 77(4):405-411. PubMed ID: 38840284
[TBL] [Abstract][Full Text] [Related]
20. MANAGEMENT OF PROSTATE CANCER IN ACCRA, GHANA.
Yeboah ED; Hsing AW; Mante S; Mensah JE; Kyei MY; Yarney J; Vanderpuye V; Beecham K; Tettey Y; Biritwum RB; Adjei AA; Gyasi R; Asante K; Ampadu KN; Klufio GO; Gepi-Attee S; Owoo C; Kwami D; Ahiaku ; Pandra R; Cook MB
J West Afr Coll Surg; 2016; 6(4):31-65. PubMed ID: 29181364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
